Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Fludarabine, cyclophosphamide, and melphalan (FCM) preconditioning in haploidentical hematopoietic stem cell transplantation for severe aplastic anemia: Update of a prospective, multicenter, single-arm clinical study

View Full Paper
Ask AI
Bookmark
Share

Authors

XLXiaoping LiTianjin Medical University General HospitalBNBo NieBeijing University of Chinese MedicinePZPeng ZhaoMinzu University of China

Discussion

Loading...

Member takes

Overview

Prospective study shows FCM preconditioning improves engraftment in severe aplastic anemia, indicating low complications and infection rates.

Key Points

  • This research aims to evaluate the efficacy and safety of FCM preconditioning in haploidentical HSCT for severe aplastic anemia.
  • Conducted a prospective, multicenter, single-arm clinical study
  • Included patients diagnosed with severe aplastic anemia requiring haploidentical HSCT
  • Administered a preconditioning regimen of fludarabine, cyclophosphamide, melphalan, and ATG
  • Monitored engraftment and complications post-transplantation
  • All patients achieved successful engraftment with median neutrophil recovery at 13 days
  • Reported a 4% transplantation-related mortality rate
  • Observed acute graft-versus-host disease in 20% of cases
  • Noted post-transplant lymphoproliferative disorder in one patient, treated successfully with rituximab

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/69362f4e4fa91c937236d89fhttps://doi.org/10.1182/blood-2025-4201
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A novel reduced-toxicity conditioning regimen with busulfan/fludarabine/cyclophosphamide/anti-thymocyte globulin for severe aplastic anemia2025
  2. 2Novel FABT-Based Conditioning Regimen with Haploidentical Transplantation for Severe Aplastic Anemia: A prospective, single-center, phase II clinical trial2026 · 4 citations
  3. 3A prospective, open, single-arm clinical trial of fludarabine- cyclophosphamide-porcine anti-lymphocyte globulin conditioning combined with matched sibling donor hematopoietic stem cell transplantation in the treatment of severe aplastic anemia2026
  4. 4The efficacy and safety of using low-dose cyclophosphamide, fludarabine and thymoglobulin in allogeneic hematopoietic stem cell transplantation for transfusion-dependent non-severe aplastic anemia：a retrospective study.2025
  5. 5Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia2024 · 1 citations